Stay current: Follow Cardiac Interventions Today on Twitter @cardiacinterv



Reva Medical’s FANTOM II Clinical Trial Expanded to Europe

April 22, 2015 -- Reva Medical, Inc. announced that the FANTOM II clinical trial of the company’s Fantom sirolimus-eluting bioresorbable scaffold is enrolling patients i…

Optimal Degree of Oversizing for TAVR Devices Evaluated

April 20, 2015 -- Danny Dvir, MD, et al published findings from an analysis of the association between CT-derived degrees of device oversizing and clinical outcomes during tra…

DEFLECT I Results Published for Keystone Heart’s EDD Used During TAVR

April 20, 2015 -- Results of the DEFLECT I study on the safety and performance of the TriGuard embolic deflection device (EDD; Keystone Heart, Ltd.) in patients undergoin…

Two-Year COAST Outcomes Support Cheatham Platinum Stent for Coarctation in Children and Adults

April 20, 2015 -- Two-year outcomes from COAST, the Coarctation of the Aorta Stent Trial, were published by Jeffery Meadows, MD, et al online ahead of print in Circulatio…

Boston Scientific Begins Novel REDUCE-HTN: REINFORCE Study of Vessix Renal Denervation System

April 16, 2015 -- Boston Scientific Corporation announced the initiation of the REDUCE-HTN: REINFORCE study, which is taking a new approach to evaluate the performan…

FDA Advisory Committee Recommends Approval of Cangrelor

April 15, 2015 -- The Medicines Company announced that the US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted 9 to 2, wi…

Senate Votes 92-8 to Repeal SGR

April 15, 2015 -- The United States Senate voted 92-8 for the passage of H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015. H.R. 2 is a bill to amend Title XVII…

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




2015 Buyer’s Guide


This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.

Website Design by Sides Media